| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.07 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |